Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1453]

Innovative treatments for solid tumours – TTFields as a therapeutic modality

Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic...

Innovative treatments for solid tumours – TTFields as a therapeutic modality ( Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic-Purkart )

Finding Grants and writing a good grant proposal

Dr Jim Biagi - Queen's University, Canada

Finding Grants and writing a good grant proposal ( Dr Jim Biagi - Queen's University, Canada )

Biostatistics for clinician researchers 2: Choosing the right statistical test

Dr Priya Ranganathan - Tata Memorial Hospital, Mumbai, India

Biostatistics for clinician researchers 2: Choosing the right statistical test ( Dr Priya Ranganathan - Tata Memorial Hospital, Mumbai, India )

Writing a protocol

Dr Susannah Stanway - UKI Global Cancer Network, London, UK

Writing a protocol ( Dr Susannah Stanway - UKI Global Cancer Network, London, UK )

Forming a team - How do I find a biostatistician in a LMIC or should I become...

Dr Bhawna Sirohi - Balco Medical Center, Raipur, India

Forming a team - How do I find a biostatistician in a LMIC or should I become one myself? ( Dr Bhawna Sirohi - Balco Medical Center, Raipur, India )

Doable clinical research in LMICs

Dr Soniya Dulal - National Academy of Medical Sciences, Nepal

Doable clinical research in LMICs ( Dr Soniya Dulal - National Academy of Medical Sciences, Nepal )

Steps in clinical research- How does one go from an idea in brain to a study on...

Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal

Steps in clinical research- How does one go from an idea in brain to a study on paper ( Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal )

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during...

Prof Gerard Zalcman - Université de Paris, Paris, France

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients ( Prof Gerard Zalcman - Université de Paris, Paris, France )

Adjuvant radiotherapy has no benefit following radical prostatectomy

Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK

Adjuvant radiotherapy has no benefit following radical prostatectomy ( Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK )

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall...

Dr Neil Gross - MD Anderson Cancer Center, Houston, USA

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC ( Dr Neil Gross - MD Anderson Cancer Center, Houston, USA )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

More from ecancer